Frontpage Mag A dangerous move.
The Food and Drug Administration recently announced it will loosen the rules to allow importation of a non-approved cancer drug from China. Ironically, this dangerous move is supposed to make up for a scarcity of critical medicines the Biden Administration itself helped to create.
Thereâs no question that prescription drug shortages are a serious problem. In the last five years, the United States has gone from 202 medicines in short supply to 301, a 49% increase. But instead of letting in a flood of risky imports, the federal government should consider reversing some of its own policies.
The administration has exacerbated drug shortages through both action and inaction. The chief cause of our current crisis is consolidation among the drug-industry middlemen known as Pharmacy Benefit Managers, or PBMs, which purchase drugs to pass on to insurers. Three giant PBMs control nearly 80% of the U.S. market for prescription medicine.
Read Full Article Here…(frontpagemag.com)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
